Benzene-1, 2, 4-tricarboxylic acid 1, 2 anhydride (trimellitic anhydride) and dicyclohexyl phthalate are identified as substances of very high concern, based on the Official Journal of the European Union released directive 2018/594 and the Official Journal of the European Union released Directive (EC) No 2018/636 respectively.
Benzene-1, 2, 4-tricarboxylic acid 1, 2 anhydride (trimellitic anhydride) (TMA), EC No 209-008-0, CAS No 552-30-7, fulfils the criterion set out in Article 57(f) of Regulation (EC) No 1907/2006 (REACH). According to the Annex XV dossier, there is scientific evidence of probable serious effects to human health due to the respiratory sensitizing properties of TMA. The data shows that TMA causes serious and permanent impairment of lung functions, if the exposure is prolonged and no intervention takes place. TMA is identified as a substance of very high concern according to Article 57(f) of REACH Regulation due to its respiratory sensitising properties. Also it shall be included in the candidate list referred to in Article 59(1) of REACH Regulation with the following indication under 'Reason for inclusion': 'Respiratory sensitising properties (Article 57(f)) – human health'.
The substance TMA is not yet included in the Candidate list. The date of inclusion will be that stated in the ECHA Executive Director’s Decision, not the date of the publication of the Commission Decision. As TMA will be a new addition, the date of inclusion will be in late June/early July, as it will be added to the list at the next scheduled update.
Dicyclohexyl phthalate (DCHP), EC No 201-545-9, CAS No 84-61-7 has reproduction toxicity of category 1B under Regulation (EC) No 1272/2008, and it has endocrine disrupting properties with probable serious effects to human health according to Article 57(f) of REACH Regulation. Besides, the substance shall be included in the candidate list referred to in Article 59(1) of REACH Regulation with the following indication under ‘Reason for inclusion’: ‘Toxic for reproduction (Article 57(c)); endocrine disrupting properties (Article 57(f) - human health)’.
The substance DCHP is not yet included in the Candidate list. The date of inclusion will be that stated in the ECHA Executive Director's Decision, not the date of the publication of the Commission Decision. As DCHP will be a new addition, the date of inclusion will be in late June/early July, as it will be added to the list at the next scheduled update.
CIRS warmly reminds that enterprises shall pay attention to the revising of REACH Regulation and SVHC, and strengthen the cooperation of professional testing agencies to prevent subsequent risks.
If you have any needs or questions, please contact us at service@cirs-group.com.
Reference: